Vimarsana
Biggest News Aggregation in the World

Page 7 - Aileen Wang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aileen Wang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aileen Wang Today - Breaking & Trending Today

Ivermectin clinical trials' start set by end of May —DOST exec - Vimarsana News

Ivermectin clinical trials' start set by end of May —DOST exec

Ivermectin clinical trials' start set by end of May —DOST exec By HANA BORDEY, GMA News Published April 24, 2021 9:35am Researchers who will work on the clinical trials of ivermectin as a potential treatment drug for COVID-19 are eyeing to start the study by end of May, an official from the Department of Science and Technology said Saturday. “Ang target po natin e magsisismula ‘yan mga katapusaan ng Mayo at ito po ay magtatagal ng tingin po namin basta mabilis ang pag-recruit ng pasyente, lalabas ang resulta after six months,” Dr. Jaime Montoya, executive director of Philippin...

PH eyes to start clinical trial on Ivermectin as COVID-19 treatment by 'first week of June' – DOST exec – Manila Bulletin - Vimarsana News

PH eyes to start clinical trial on Ivermectin as COVID-19 treatment by 'first week of June' – DOST exec – Manila Bulletin

Published April 23, 2021, 4:22 PM The Philippines is targeting to conduct its clinical trial on the use of Ivermectin as a treatment for coronavirus disease (COVID-19) by “first week of June”, a top official of the Department of Science and Technology-Philippine Council for Health Research and Development (DOST-PCHRD) said on Friday, April 23. DOST-PCHRD Executive Director Dr. Jaime C. Montoya confirmed that the research team from the University of the Philippines (UP) Manila- Philippine General Hospital (PGH), to be led by Dr. Aileen Wang will conduct the clinical trial. DOST-PCHRD Execu...

Source: mb.com.ph
TodayIR: China New Higher Education Group: Highest Target Price Reached HK$8.40 Stable Growth with Promising Prospect, China New Higher Education Group Favored by the Market - Vimarsana News

TodayIR: China New Higher Education Group: Highest Target Price Reached HK$8.40 Stable Growth with Promising Prospect, China New Higher Education Group Favored by the Market

(2) DJ EQS-News: Highest Target Price Reached HK$8.40 Stable Growth with Promising Prospect, China New Higher Education Group Favored by the Market EQS-News / 31/12/2020 / 09:44 UTC+8 Immediate release 31 December 2020 (Stock Code: 2001.HK) [1] Highest Target Price Reached HK$8.40 Stable Growth with Promising Prospect, China New Higher Education Group Favored by the Market (31 December 2020 - Hong Kong) China New Higher Education Group Co., Ltd. ("China New Higher Education Group", together with its subsidiaries...

TodayIR: China New Higher Education Group Wins Two Honors: ListCo Excellence Awards 2020 and Award of Hong Kong Outstanding Enterprises Parade 2020 (Main Board category) - Vimarsana News

TodayIR: China New Higher Education Group Wins Two Honors: ListCo Excellence Awards 2020 and Award of Hong Kong Outstanding Enterprises Parade 2020 (Main Board category)

(1) DJ EQS-News: China New Higher Education Group Wins Two Honors: ListCo Excellence Awards 2020 and Award of Hong Kong Outstanding Enterprises Parade 2020 (Main Board category) EQS-News / 23/12/2020 / 14:57 UTC+8 Immediate release 23 December 2020 (Stock code: 2001. HK) China New Higher Education Group Wins Two Honors: ListCo Excellence Awards 2020 and Award of Hong Kong Outstanding Enterprises Parade 2020 (Main Board category) (23 December 2020, Hong Kong) China New Higher Education Group Limited ("China New Higher ...